View
Semantic Search: Lilly Flags New Court Ruling as Telehealth GLP-1 Lawsuits Begin to Converge
Lilly Flags New Court Ruling as Telehealth GLP-1 Lawsuits Begin to Converge
Score 0.899
· Account tjphuhs@gmail.com
· 3/13/2026, 5:29:55 PM
Lilly Flags New Court Ruling as Telehealth GLP-1 Lawsuits Begin to Converge from onthepen@substack.com on 2026-03-13T21:29:55.000Z View this post on the web at https://onthepen.substack.com/p/lilly-flags-new-court-ruling-as-telehealth Eli Lilly quietly filed a Statement of Recent Decision this week in its lawsuit against Mochi Health, pointing the judge to a recent federal ruling that could influence how the case proceeds. The move is procedural but strategic, and it signals that the pharmaceuti
Lilly Flags New Court Ruling as Telehealth GLP-1 Lawsuits Begin to Converge
Score 0.863
· Account tjphuhs@gmail.com
· 3/13/2026, 5:29:55 PM
Lilly Flags New Court Ruling as Telehealth GLP-1 Lawsuits Begin to Converge from onthepen@substack.com on 2026-03-13T21:29:55.000Z is important because federal courts have historically been cautious about stepping into disputes that fall within the FDA’s enforcement authority. In several previous cases involving pharmaceutical marketing claims, judges have ruled that questions about drug labeling and promotional language are issues that regulators, not courts, are typically responsible for polic
Lilly Flags New Court Ruling as Telehealth GLP-1 Lawsuits Begin to Converge
Score 0.854
· Account tjphuhs@gmail.com
· 3/13/2026, 5:29:55 PM
Lilly Flags New Court Ruling as Telehealth GLP-1 Lawsuits Begin to Converge from onthepen@substack.com on 2026-03-13T21:29:55.000Z NEW STUDIO WE ARE BUILDING. EVERY DOLLAR MADE BETWEEN NOW AND OUR LAUNCH WILL GO TOWARDS HELPING US TURN THIS INTO THE FIRST EVER PRODUCTION STUDIO DEDICATED TO OBESITY MEDICINE NEWS. IF YOU BELIEVE IN IT, CONSIDER “PUTTING YOUR NAME ON IT” TODAY! Unsubscribe https://substack.com/redirect/2/eyJlIjoiaHR0cHM6Ly9vbnRoZXBlbi5zdWJzdGFjay5jb20vYWN0aW9uL2Rpc2FibGVfZW1haWw_d
BREAKING: Two Stories That Impact Compounded GLP-1
Score 0.751
· Account tjphuhs@gmail.com
· 4/30/2026, 10:32:22 PM
BREAKING: Two Stories That Impact Compounded GLP-1 from onthepen@substack.com on 2026-05-01T02:32:22.000Z View this post on the web at https://onthepen.substack.com/p/breaking-two-stories-that-impact A federal judge just handed Eli Lilly a mixed ruling in its lawsuit against Empower Pharmacy. At almost the same time, the FDA quietly proposed something that could matter even more long term: formally declaring that there is no “clinical need” to compound semaglutide, tirzepatide, or liraglutide at
Fwd: Come Follow the Lilly Earnings Call With Me
Score 0.648
· Account oc.tjphuhs@gmail.com
· 4/30/2026, 11:00:39 AM
Fwd: Come Follow the Lilly Earnings Call With Me from tjphuhs@gmail.com on 2026-04-30T15:00:39.000Z ---------- Forwarded message ---------- From: Dave Knapp from On The Pen <onthepen@substack.com> Date: Apr 30, 2026 at 9:42 AM -0400 To: tjphuhs@gmail.com Subject: Come Follow the Lilly Earnings Call With Me > Lilly earnings are this morning. > ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Fwd: Come Follow the Lilly Earnings Call With Me
Score 0.648
· Account tjphuhs@gmail.com
· 4/30/2026, 11:00:39 AM
Fwd: Come Follow the Lilly Earnings Call With Me from tjphuhs@gmail.com on 2026-04-30T15:00:39.000Z ---------- Forwarded message ---------- From: Dave Knapp from On The Pen <onthepen@substack.com> Date: Apr 30, 2026 at 9:42 AM -0400 To: tjphuhs@gmail.com Subject: Come Follow the Lilly Earnings Call With Me > Lilly earnings are this morning. > ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Fwd: Compound Tirzepatide & Semaglutide Updates!
Score 0.644
· Account tjphuhs@gmail.com
· 3/17/2026, 5:51:48 PM
Fwd: Compound Tirzepatide & Semaglutide Updates! from tjphuhs@gmail.com on 2026-03-17T21:51:48.000Z exclusive DDC list explained Novo’s lab findings 302% dose shocker Catalent’s contamination mess Lilly’s B12 tirzepatide bombshell Is the molecule changing? New oral GLP-1 contender MASSIVE: Compound Tirzepatide and Semaglutide Updates! Dave Knapp GLP-1 Industry Insider Episode Do you trust compounded GLP-1s based on real-world experience, or do findings like the ones discussed today change your p
GLP-1 Access State of the Union
Score 0.638
· Account tjphuhs@gmail.com
· 4/7/2026, 4:01:22 PM
GLP-1 Access State of the Union from onthepen@substack.com on 2026-04-07T20:01:22.000Z View this post on the web at https://onthepen.substack.com/p/glp-1-access-state-of-the-union If you just look at the headlines, things look great for access to GLP-1 medications but for some of those already using these medications things are changing and getting tighter. Listen in as Dave breaks down the news of the week and puts it all in context. Watch or listen to this week’s podcast on Spotify! If you pre
Fwd: GLP-1 Pregnancy Fears vs Reality… The First Real Data Is In
Score 0.638
· Account tjphuhs@gmail.com
· 4/7/2026, 1:00:10 PM
Fwd: GLP-1 Pregnancy Fears vs Reality… The First Real Data Is In from tjphuhs@gmail.com on 2026-04-07T17:00:10.000Z ---------- Forwarded message ---------- From: Dave Knapp from On The Pen <onthepen@substack.com> Date: Mar 28, 2026 at 1:38 PM -0400 To: tjphuhs@gmail.com Subject: GLP-1 Pregnancy Fears vs Reality… The First Real Data Is In > If you’re currently on a GLP-1, or if you’ve been on one long enough to feel your body experience massive changes, you already understand why this conversatio
Fwd: GLP-1 Pregnancy Fears vs Reality… The First Real Data Is In
Score 0.638
· Account oc.tjphuhs@gmail.com
· 4/7/2026, 1:00:10 PM
Fwd: GLP-1 Pregnancy Fears vs Reality… The First Real Data Is In from tjphuhs@gmail.com on 2026-04-07T17:00:10.000Z ---------- Forwarded message ---------- From: Dave Knapp from On The Pen <onthepen@substack.com> Date: Mar 28, 2026 at 1:38 PM -0400 To: tjphuhs@gmail.com Subject: GLP-1 Pregnancy Fears vs Reality… The First Real Data Is In > If you’re currently on a GLP-1, or if you’ve been on one long enough to feel your body experience massive changes, you already understand why this conversatio
What Lilly’s Earnings Call Just Revealed About the Future of Obesity Treatment
Score 0.638
· Account tjphuhs@gmail.com
· 4/30/2026, 1:08:23 PM
What Lilly’s Earnings Call Just Revealed About the Future of Obesity Treatment from onthepen@substack.com on 2026-04-30T17:08:23.000Z View this post on the web at https://onthepen.substack.com/p/what-lillys-earnings-call-just-revealed There was a moment in this call for me where all of the incredibly impressive numbers stopped meaning much to me, and the structure underneath them started to matter a lot more. Lilly reported $12.8 billion in combined revenue for Mounjaro and Zepbound, with prescr
Come Follow the Lilly Earnings Call With Me
Score 0.632
· Account tjphuhs@gmail.com
· 4/30/2026, 9:42:29 AM
Come Follow the Lilly Earnings Call With Me from onthepen@substack.com on 2026-04-30T13:42:29.000Z View this post on the web at https://onthepen.substack.com/p/come-follow-the-lilly-earnings-call Lilly earnings are this morning. I’ll be live tweeting my instant reactions on X. Real-time updates, for those who can’t listen… This is going to be an interesting call with lots of pipeline discussion! 👉 Follow along here Later today I’ll be dropping my video roundup, the full picture, and what it mea
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.631
· Account tjphuhs@gmail.com
· 4/24/2026, 9:05:46 AM
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from derekpruski@substack.com on 2026-04-24T13:05:46.000Z single dose and push efficacy into territory that previously only bariatric surgery could reach. ═══════════════════════════════ THE FIVE RECEPTORS AND WHY EACH MATTERS The rumored Lilly quintuple reportedly targets GLP-1, GIP, glucagon, amylin, and calcitonin. Let’s break down what each one actually does. GLP-1 (Glucagon-Like Peptide-1) This is the backbone of every m
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.628
· Account tjphuhs@gmail.com
· 4/24/2026, 9:42:34 AM
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from tjphuhs@gmail.com on 2026-04-24T13:42:34.000Z > • > News-Medical coverage: “New quintuple agonist shows promise for treating obesity and type 2 diabetes.” September 21, 2025. news-medical.net > • > Andreassen KV, et al. Research on Dual Amylin and Calcitonin Receptor Agonists (DACRAs, KBP-042, KBP-089) — various publications > • > Eli Lilly pipeline page (no quintuple currently listed): lilly.com/science/research-de
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.628
· Account oc.tjphuhs@gmail.com
· 4/24/2026, 9:42:34 AM
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from tjphuhs@gmail.com on 2026-04-24T13:42:34.000Z > • > News-Medical coverage: “New quintuple agonist shows promise for treating obesity and type 2 diabetes.” September 21, 2025. news-medical.net > • > Andreassen KV, et al. Research on Dual Amylin and Calcitonin Receptor Agonists (DACRAs, KBP-042, KBP-089) — various publications > • > Eli Lilly pipeline page (no quintuple currently listed): lilly.com/science/research-de
The GLP-1 Moment Is Breaking the Healthcare System Wide Open
Score 0.628
· Account tjphuhs@gmail.com
· 3/18/2026, 6:27:27 PM
The GLP-1 Moment Is Breaking the Healthcare System Wide Open from onthepen@substack.com on 2026-03-18T22:27:27.000Z View this post on the web at https://onthepen.substack.com/p/the-glp-1-moment-is-breaking-the I’ve said this a number of times, but it keeps proving itself out. GLP-1 medications are not just transforming lives, they’re transforming our healthcare system in a way we haven’t seen in decades, and it’s happening faster than most people realize. What started as a shortage story, and on
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.627
· Account oc.tjphuhs@gmail.com
· 4/24/2026, 9:42:34 AM
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from tjphuhs@gmail.com on 2026-04-24T13:42:34.000Z PPAR part is only released inside cells that express GLP-1 or GIP receptors, so it’s targeted rather than systemic. > Mouse models showed it outperformed GLP-1/GIP co-agonism alone on both weight and glucose control. > This is academic preclinical work — not owned by Lilly, not in human trials — but it demonstrates that pushing past three receptor targets is a legitimate
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.627
· Account tjphuhs@gmail.com
· 4/24/2026, 9:42:34 AM
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from tjphuhs@gmail.com on 2026-04-24T13:42:34.000Z PPAR part is only released inside cells that express GLP-1 or GIP receptors, so it’s targeted rather than systemic. > Mouse models showed it outperformed GLP-1/GIP co-agonism alone on both weight and glucose control. > This is academic preclinical work — not owned by Lilly, not in human trials — but it demonstrates that pushing past three receptor targets is a legitimate
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.625
· Account tjphuhs@gmail.com
· 4/24/2026, 9:05:46 AM
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from derekpruski@substack.com on 2026-04-24T13:05:46.000Z control (the tirzepatide backbone) Adding glucagon brings fat-burning and energy expenditure (the retatrutide upgrade) Adding amylin brings extended satiety and slowed gastric emptying from a different pathway Adding calcitonin brings longer-duration satiety, insulin sensitivity, and bone/joint protection On paper, you’d be combining the best of everything that’s alrea
BREAKING: Two Stories That Impact Compounded GLP-1
Score 0.624
· Account tjphuhs@gmail.com
· 4/30/2026, 10:32:22 PM
BREAKING: Two Stories That Impact Compounded GLP-1 from onthepen@substack.com on 2026-05-01T02:32:22.000Z The Reality for Patients Patients did not turn to compounded GLP-1s because they wanted a workaround. They turned to them because the branded medications were out of stock, out of reach, imprecisely dosed, or excluded by their insurance. Compounding was not a loophole. For hundreds of thousands of people, it was the only path forward. The FDA’s position is now clear. Affordability is not a c
Fwd: Come Follow the Lilly Earnings Call With Me
Score 0.623
· Account tjphuhs@gmail.com
· 4/30/2026, 11:00:39 AM
Fwd: Come Follow the Lilly Earnings Call With Me from tjphuhs@gmail.com on 2026-04-30T15:00:39.000Z · Apr 30, 2026 · 28 Views > 1 Like > Later today I’ll be dropping my video roundup, the full picture, and what it means for patients... > Here are my two favorite slides to look at for what’s upcoming in obesity medicine: > VISIT OUR SPONSORS! > You’re currently a free subscriber to On The Pen. For premium access to insider articles, upgrade to paid. > Upgrade to paid > > Share > > > Like > Commen
Fwd: Come Follow the Lilly Earnings Call With Me
Score 0.623
· Account oc.tjphuhs@gmail.com
· 4/30/2026, 11:00:39 AM
Fwd: Come Follow the Lilly Earnings Call With Me from tjphuhs@gmail.com on 2026-04-30T15:00:39.000Z · Apr 30, 2026 · 28 Views > 1 Like > Later today I’ll be dropping my video roundup, the full picture, and what it means for patients... > Here are my two favorite slides to look at for what’s upcoming in obesity medicine: > VISIT OUR SPONSORS! > You’re currently a free subscriber to On The Pen. For premium access to insider articles, upgrade to paid. > Upgrade to paid > > Share > > > Like > Commen
The Next Wave of GLP-1s Is Coming
Score 0.622
· Account tjphuhs@gmail.com
· 3/31/2026, 6:05:53 PM
The Next Wave of GLP-1s Is Coming from huntershealthhacks@mail.beehiiv.com on 2026-03-31T22:05:53.000Z Happy Tuesday! There are two peptides quietly making waves in the clinical space that will demand all of our attention over the next 24 months. They don't work like semaglutide, they don't work like tirzepatide, and the clinical data is turning heads. I just dropped a brand new video breaking down survodutide and mazdutide. Survodutide & Mazdutide | The GLP-1/Glucagon Duo That Could Rival Reta:
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.614
· Account tjphuhs@gmail.com
· 4/24/2026, 9:05:46 AM
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from derekpruski@substack.com on 2026-04-24T13:05:46.000Z in human trials — but it demonstrates that pushing past three receptor targets is a legitimate and productive research direction. Different compound, same direction of travel. ═══════════════════════════════ THE CURRENT LANDSCAPE — WHAT’S ACTUALLY IN TRIALS To keep perspective on where the quintuple fits in, here’s what’s actually advancing right now. Retatrutide (Trip
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.614
· Account tjphuhs@gmail.com
· 4/24/2026, 9:05:46 AM
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from derekpruski@substack.com on 2026-04-24T13:05:46.000Z still mouse data Mouse-to-market is typically 8-12 years Retatrutide is what’s actually arriving soon Eloralintide is what’s actually advancing through Phase 3 for amylin The quintuple, if real, is a late-decade story The most important thing to do right now is stay curious and stay patient. Let the science play out. Don’t build expectations around compounds that haven